a<p>EC<sub>50</sub> required to inhibit virus-induced cytopathicity in CEM (HIV-1 III<sub>B</sub>) cell cultures by 50%.</p>b<p>EC<sub>50</sub> required to inhibit virus (HIV-1 NL4.3)-induced cytopathicity in C8166 cell cultures by 50%.</p>c<p>50%-Effective concentration or compound concentration required to inhibit syncytia formation between persistently HIV-1(III<sub>B</sub>)-infected HuT-78/HIV-1 cells and uninfected CD4<sup>+</sup> T-lymphocyte Sup T1 cells by 50%.</p>d<p>50%-Effective concentration or compound concentration required to inhibit syncytia formation between persistently HIV-1(III<sub>B</sub>)-infected HuT-78/HIV-1 cells and uninfected CD4<sup>+</sup> T-lymphocyte C8166 cells by 50%.</p><p>The data from which the EC<sub>50</sub>'s were derived are shown in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0064132#pone.0064132.s001" target="_blank">Figures S1</a>, <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0064132#pone.0064132.s002" target="_blank">S2</a>, <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0064132#pone.0064132.s003" target="_blank">S3</a>, <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0064132#pone.0064132.s004" target="_blank">S4</a>, <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0064132#pone.0064132.s005" target="_blank">S5</a> and are the mean of at least 2 to 3 independent experiments.</p
